- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| PHARMASIMPLE Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INNOCAN PHARMA | 4,440 | +3,26 % | Innocan Pharma Corporation: Innocan Pharma Announces Closing of a Debenture to its Largest Shareholder, Tamar Innovest | HERZLIYA, Israel and CALGARY, AB, March 16, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it... ► Artikel lesen | |
| SYNBIOTIC | 1,964 | -8,01 % | EQS-News: SYNBIOTIC SE: Globale Dynamik im Cannabismarkt: Neue Signale aus den USA stärken langfristige Perspektiven für Europa und SYNBIOTIC | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Marktbericht/Sonstiges
Globale Dynamik im Cannabismarkt: Neue Signale aus den USA stärken langfristige Perspektiven für Europa und SYNBIOTIC... ► Artikel lesen | |
| BIONANO GENOMICS | 1,130 | +2,73 % | Bionano Genomics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call | ||
| AXSOME THERAPEUTICS | 136,50 | -0,18 % | RBC Capital reiterates Axsome Therapeutics stock rating at Outperform | ||
| JAGUAR HEALTH | 0,400 | 0,00 % | Jaguar Health, Inc.: FDA Feedback Supports Extension Phase for Jaguar Health's Clinical Trial of Crofelemer for Treatment of Microvillus Inclusion Disease | MVID has a lethal natural history requiring life-sustaining parenteral support (PS), which includes total parenteral nutrition (TPN), which is associated with significant toxicities; PS reduction could... ► Artikel lesen | |
| TRULIEVE CANNABIS | 5,315 | -1,39 % | Trulieve Announces Executive Automatic Securities Disposition Plan | ||
| WEST PHARMACEUTICAL SERVICES | 206,70 | -0,39 % | West Pharmaceutical Services skizziert Wachstumsstrategie auf KeyBanc Forum | ||
| KALA BIO | 0,194 | -9,79 % | Red Light Holland Corp.: Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate | AI-powered autonomous research agents to be deployed in support of PEX010 clinical development strategy, leveraging Kala Bio's purpose-built agentic AI platform for the biotechnology industryToronto... ► Artikel lesen | |
| SHIONOGI | 18,600 | +1,09 % | Cumulus Neuroscience Enters Japanese Market to Advance Novel Cognitive Biomarkers with New Customer Shionogi & Co., Ltd. | BELFAST, Northern Ireland, Feb. 10, 2026 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and... ► Artikel lesen | |
| THERIVA BIOLOGICS | 0,186 | 0,00 % | Theriva Biologics, Inc.: Theriva Biologics Reports Full-Year 2025 Operational Highlights and Financial Results | - Advancing clinical development of VCN-01 for pancreatic ductal adenocarcinoma and retinoblastoma -
- Licensed SYN-020 to Rasayana Therapeutics for development in multiple indications; up to $38... ► Artikel lesen | |
| CHARLOTTES WEB | 0,645 | -10,42 % | Charlotte's Web Holdings, Inc.: Charlotte's Web Reports Q3 2025 Results | Healthcare Focus, Product Innovation, and Cost Improvements
LOUISVILLE, Colo., Nov. 12, 2025 /PRNewswire/ - (TSX: CWEB) (OTC: CWBHF), Charlotte's Web Holdings,... ► Artikel lesen | |
| NRX PHARMACEUTICALS | 1,630 | +1,88 % | NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) to Report Full Year 2025 Financial Results and Provide a Corporate Update on March 24, 2026 | ||
| BEXIMCO PHARMACEUTICALS | 0,466 | +3,56 % | Beximco Pharma: Gerichtsanhörung auf nach April verschoben | ||
| THERAPEUTICSMD | 1,860 | +0,54 % | XFRA NEW INSTRUMENTS AVAILABLE ON 10.12.2025 | The following instruments on XETRA do have their first trading 10.12.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 10.12.2025
Aktien
1 JP3108030002 Axyz Co. Ltd.
2 JP3431200009... ► Artikel lesen | |
| LUYE PHARMA | 0,256 | -3,76 % | LUYE PHARMA (02186): NOTICE OF BOARD MEETING |
Das Unternehmen PHARMASIMPLE SA kann der Branche Pharma zugeordnet werden.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PHARMASIMPLE SA finden Sie auf Wallstreet Online.